KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Inventory Average (2016 - 2025)

Historic Inventory Average for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Q3 2025 value amounting to $1.4 billion.

  • Biomarin Pharmaceutical's Inventory Average rose 1520.9% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 1520.9%. This contributed to the annual value of $1.2 billion for FY2024, which is 1691.78% up from last year.
  • As of Q3 2025, Biomarin Pharmaceutical's Inventory Average stood at $1.4 billion, which was up 1520.9% from $1.3 billion recorded in Q2 2025.
  • Biomarin Pharmaceutical's Inventory Average's 5-year high stood at $1.4 billion during Q3 2025, with a 5-year trough of $706.2 million in Q1 2021.
  • In the last 5 years, Biomarin Pharmaceutical's Inventory Average had a median value of $947.2 million in 2023 and averaged $984.0 million.
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Inventory Average plummeted by 169.71% in 2021, and later soared by 2383.67% in 2024.
  • Biomarin Pharmaceutical's Inventory Average (Quarter) stood at $763.0 million in 2021, then grew by 13.59% to $866.8 million in 2022, then increased by 23.41% to $1.1 billion in 2023, then grew by 12.74% to $1.2 billion in 2024, then rose by 12.87% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.